ストックスクリーナーアプリを入手
108.97
0.98%
0.7496
Haemonetics Corp (HAE) 最新ニュース
HAE Maintained by Baird -- Price Target Raised to $119.00 - GuruFocus
Robert W. Baird Issues Positive Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat
Haemonetics: Worth Speculating On This Recurring Medtech Plasma Model (NYSE:HAE) - Seeking Alpha
26,280 Shares in Haemonetics Corporation $HAE Acquired by Nierenberg Investment Management Company LLC - MarketBeat
Aurora Investment Counsel Acquires New Position in Haemonetics Corporation $HAE - MarketBeat
Haemonetics stock hits 52-week high at 106.64 USD By Investing.com - Investing.com South Africa
HAE Maintains by Barrington Research -- Price Target Raised to $118 - GuruFocus
HAEMONETICS CORP : BARRINGTON RESEARCH RAISES TARGET PRICE TO $118 FROM $95 - Bitget
Haemonetics stock hits 52-week high at 106.64 USD - Investing.com
Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating - marketscreener.com
Haemonetics Shares Hit New 52-Week High: What's Happening? - Sahm
Is Haemonetics’ (HAE) ESOP Shelf Move Reframing Its Balance Between Growth Investment and Shareholder Dilution? - simplywall.st
Haemonetics Corp (HAE) Shares Surge 15.9% -- What GF Score of 85 Tells Investors - GuruFocus
HAE Maintained by BTIG -- Price Target Raised to $110 - GuruFocus
Haemonetics (HAE) Stock Climbs As Analysts Hike Price Targets - StocksToTrade
Form 8K Haemonetics Corp For: 18 August By Investing.com - Investing.com Australia
Haemonetics Jumps as Investors Cheer Raised Fiscal 2027 Outlook - Quiver Quantitative
HAE Looks 23.1% Overvalued on GF Value™ - GuruFocus
Haemonetics stock surges 16% on CSL Plasma supply deal By Investing.com - Investing.com Australia
Haemonetics stock surges 16% on CSL Plasma supply deal - Investing.com
HAE Looks 21.1% Overvalued on GF Value™ as Stock Surges to $104 - GuruFocus
Haemonetics (NYSE:HAE) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Haemonetics (NYSE:HAE) Price Target Raised to $110.00 at BTIG Research - MarketBeat
Haemonetics Announces Non-Exclusive Supply Agreement with CSL Plasma for NexSys PCS Devices - Kalkine Media
HAE Looks 5.9% Overvalued on GF Value™ as Supply Deal with CSL P - GuruFocus
Why is Haemonetics stock surging today? - Investing.com
Why is Haemonetics stock surging today? By Investing.com - Investing.com Australia
Haemonetics announces non-exclusive supply agreement with CSL Plasma By Investing.com - Investing.com Australia
Haemonetics rises after supply deal with CSL - seekingalpha.com
Haemonetics announces non-exclusive supply agreement with CSL Plasma - Investing.com
Haemonetics signs non-exclusive U.S. supply deal with CSL Plasma for NexSys PCS devices - TradingView
Rice Hall James & Associates LLC Makes New Investment in Haemonetics Corporation $HAE - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Haemonetics (HAE) Q1 2027 Earnings Call Transcript - AOL.com
Haemonetics (HAE) Stock Could Be 49% Below Fair Value On Raised Guidance - Yahoo Finance
Haemonetics (HAE) Earnings Beat Puts Fair Value Back In Focus - Yahoo Finance
Haemonetics (NYSE:HAE) Shines in Quality Investing Screen - ChartMill
5 Insightful Analyst Questions From Haemonetics’s Q2 Earnings Call - Yahoo Finance
John Rogers's Top Q2 2026 Move: Haemonetics Corp at a 1.54% Portfolio Impact - Yahoo Finance
John Rogers's Top Q2 2026 Move: Haemonetics Corp at a 1.54% Port - GuruFocus
HAE Stock Gains on Q1 Earnings & Revenue Beat, Fiscal '27 View Up - Yahoo Finance
Assenagon Asset Management S.A. Sells 142,292 Shares of Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corporation (NYSE:HAE) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Haemonetics Corp (HAE) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 77/100 - GuruFocus
AQR Capital discloses 4.99% Haemonetics Corp (HAE) position in Schedule 13G/A - Stock Titan
Mizuho Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $95 - Moomoo
Quantinno Capital Management LP Has $1.73 Million Stock Holdings in Haemonetics Corporation $HAE - MarketBeat
Does Strong Q1 Results And VASCADE Data Shift The Bull Case For Haemonetics (HAE)? - simplywall.st
Haemonetics (NYSE:HAE) Sets New 12-Month HighStill a Buy? - MarketBeat
Haemonetics stock hits 52-week high at 88.73 USD By Investing.com - Investing.com South Africa
Haemonetics stock hits 52-week high at 88.73 USD - Investing.com
Haemonetics (HAE) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Renaissance Technologies LLC Takes $2.44 Million Position in Haemonetics Corporation $HAE - MarketBeat
HAE Q2 Deep Dive: Plasma and Interventional Growth Drive Outperformance, Margin Outlook Steady - Yahoo Finance
Haemonetics Corporation (HAE) Stock forecasts - Yahoo Finance Singapore
1.36%
大文字化:
|
ボリューム (24 時間):